Beth Tran, global business manager, CR Excipients, Colorcon, explains how innovations in controlled release systems, film coatings and functional excipients are driving the future of drug delivery.
Honeywell Energy is partnering with DevPro Biopharma to develop an innovative respiratory inhaler that enables individuals to manage their respiratory conditions offering significant reductions in carbon emissions.
SHL Medical has adopted a new reusable electromechanical autoinjector Elexy which changes how new drugs are trialled and commercialised, shortening these processes.
Semaglutide usage has surged in recent years due to FDA approval for its wider usage in weight loss management, providing a legal and regulated avenue for the drug to be prescribed.
Molex, parent company of Phillips Medisize, has announced that it has signed an agreement to purchase Vectura Group Limited, a leader in inhalation drug device design and formulation.
In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market.
In our latest EPM Online Insight, ACG's Subhashis Chakraborty and Shincy Jacob attempt to answer what groundbreaking innovations lie ahead for capsules, and how will these developments redefine their role in the evolving landscape of drug delivery?
In this article, Dr. Asma Patel, Vice President of Integrated Development Services at Quotient Sciences, explores the benefits of MR formulations, highlighting the importance of an effective strategy for MR development.
